Experiences of a multidisciplinary genomic tumor board interpreting risk for underlying germline variants in tumor-only sequencing results.
Fishler, KP; Breese, EH; Walters-Sen, L; McGowan, ML.
JCO Precision Oncology.
2019;
3:1-8.
Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis.
Young, J; Sawyer, J; Jenkins, M; O'Brien, M; Luchtman-Jones, L; Breese, EH.
Pediatric Blood and Cancer.
2019;
66:e27719-e27719.
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
Gurunathan, A; Boucher, AA; Mark, M; Prus, KM; O'Brien, MM; Breese, EH; Mizukawa, BE; Absalon, MJ; Nelson, AS; Jordan, MB; et al.
Pediatric Blood and Cancer.
2018;
65:e27400-e27400.
MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.
Schneidawind, C; Jeong, J; Schneidawind, D; Kim, I; Duque-Afonso, J; Wong, SH K; Iwasaki, M; Breese, EH; Zehnder, JL; Porteus, M; et al.
Blood Advances.
2018;
2:832-845.
Viral surveillance using PCR during treatment of AML and ALL.
Dixon, SB; Lane, A; O'Brien, MM; Burns, KC; Mangino, JL; Breese, EH; Absalon, MJ; Perentesis, JP; Phillips, CL.
Pediatric Blood and Cancer.
2018;
65:e26752-e26752.